Literature DB >> 22374407

Could FFAR1 assist insulin secretion in type 2 diabetes?

Clifford J Bailey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22374407     DOI： 10.1016/S0140-6736(12)60165-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  New therapeutic efforts and upcoming developments in the field of diabetes medicine and endocrinology.

Authors:  Christoph Schindler
Journal:  Ther Adv Endocrinol Metab       Date:  2012-04       Impact factor: 3.565

2.  Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial.

Authors:  K Kaku; K Enya; R Nakaya; T Ohira; R Matsuno
Journal:  Diabetes Obes Metab       Date:  2015-04-23       Impact factor: 6.577

Review 3.  Treatment of type 2 diabetes by free Fatty Acid receptor agonists.

Authors:  Kenneth R Watterson; Brian D Hudson; Trond Ulven; Graeme Milligan
Journal:  Front Endocrinol (Lausanne)       Date:  2014-08-28       Impact factor: 5.555
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.